Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in PDSB — PDS Biotechnology Corp

CIK 72971 SAN FRANCISCO, CA
Back to PDSB Full portfolio

Position in PDSB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$96,029
+$29,177 QoQ
Shares Held
109,000
-1.4% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 52 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 3% Shared 0% None 97%

Common Shares in PDSB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. PDSB ranks #290 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in PDSB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $96,029 109,000
2026-03-31 $66,852 110,500
2025-12-31 $4,103 5,329
2025-09-30 $5,382 5,329
2025-06-30 $7,087 5,329
2025-03-31 $6,341 5,329
2024-12-31 $7,871 4,829
2024-09-30 $18,064 4,729
2024-06-30 $10,255 3,500
2024-03-31 $41,536 10,489
2023-12-31 $36,107 7,265
2023-09-30 $30,132 5,967
2023-06-30 $86,721 17,241
2023-03-31 $33,210 5,400
2022-12-31 $334,540 25,344
2022-09-30 $76,370 25,714
2022-06-30 $605 166
2022-03-31 $940 152
2021-12-31 $1,231 152
2021-09-30 $2,190 147
2021-06-30 $1,543 123
2021-03-31 $564 124
2020-12-31 $267 125
2020-09-30 $172 74
2020-06-30 $148 74
2020-03-31 $54 75